Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer
Local Advanced or Metastatic NSCLC
Shanghai JMT-Bio Inc.monoclonal_antibodyPhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 58/ 100
- Competitive Position
- 95/ 100
Competitive context
1205 Active assets in the Local Advanced or Metastatic NSCLC cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Zorifertinib Alpha Biopharma (Jiangsu) Co., Ltd. | Phase 2/3 | BBB |
Necitumumab Jonsson Comprehensive Cancer Center | Phase 3 | BBB |
Glumetinib Shanghai JMT-Bio Inc. | Phase 3 | BBB |
Zoledronate Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 4 | BBB |
d-0316 Betta Pharmaceuticals Co., Ltd. | Phase 2/3 | BBB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →